[SCHEDULE 13G] DENTSPLY SIRONA Inc. Passive Investment Disclosure (>5%)
Southpoint reports 10M shares (5.0%) in Dentsply Sirona
Southpoint Master Fund, LP and affiliated filers reported beneficial ownership of 10,000,000 shares of Dentsply Sirona Inc. Common Stock (CUSIP 24906P109), representing 5.0% of the class.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Southpoint Master Fund, LP and affiliated filers reported beneficial ownership of 10,000,000 shares of Dentsply Sirona Inc. Common Stock (CUSIP 24906P109), representing 5.0% of the class. The shares are reported as held with shared voting and shared dispositive power of 10,000,000.
The filing is a joint Schedule 13G listing Southpoint Master Fund, LP; Southpoint Capital Advisors LP; Southpoint Capital Advisors LLC; Southpoint GP, LP; Southpoint GP, LLC; and John S. Clark II as reporting persons. The ownership percentages are calculated using 199,749,333 shares outstanding as of February 20, 2026.
Insights
Schedule 13G shows a passive 5.0% stake held jointly by Southpoint entities.
The filing lists 10,000,000 shares with shared voting and dispositive power, indicating the position is reported across multiple related entities and an individual acting as managing member. The filing is presented as a joint filing agreement.
Ownership is calculated on 199,749,333 shares outstanding as of February 20, 2026. The filing does not state any plans to acquire or dispose; subsequent filings would show changes.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake did Southpoint report in Dentsply Sirona (XRAY)?
Southpoint reported ownership of 10,000,000 shares, representing 5.0% of common stock. The figure is based on 199,749,333 shares outstanding as of February 20, 2026 from the issuer's Form 10-K.
Which entities are included in the joint 13G filing for XRAY?
The joint filing names Southpoint Master Fund, LP, Southpoint Capital Advisors LP, Southpoint Capital Advisors LLC, Southpoint GP, LP, Southpoint GP, LLC, and John S. Clark II as the reporting persons under the agreement.
Does the filing indicate whether Southpoint has sole voting power?
No; the filing shows 0 shares of sole voting power and reports 10,000,000 shares of shared voting power. It explicitly lists shared voting and shared dispositive power for the reported shares.
What date is used to calculate the percentage ownership in the 13G?
The ownership percentage is calculated using the issuer's reported total of 199,749,333 shares outstanding as of February 20, 2026, as cited in the issuer's Annual Report on Form 10-K.
Did the filing state any intent to buy or sell additional XRAY shares?
The Schedule 13G filing presents the position as held by reporting persons and does not state any intent to acquire or dispose of additional shares; no purchase or sale plans are disclosed in the provided excerpt.
The name of the persons filing this report (the "Reporting Persons") with respect to shares of Common Stock, par value $0.01 per share (the "Common Stock") of Dentsply Sirona Inc. (the "Issuer") are:
(i) Southpoint Master Fund, LP
(ii) Southpoint Capital Advisors LP
(iii) Southpoint Capital Advisors LLC
(iv) Southpoint GP, LP
(v) Southpoint GP, LLC
(vi) John S. Clark II
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is:
1114 Avenue of the Americas, 22nd Floor New York, NY 10036
(c)
Citizenship:
Southpoint Master Fund, LP: Cayman Islands
Southpoint Capital Advisors LP: Delaware
Southpoint Capital Advisors LLC: Delaware
Southpoint GP, LP: Delaware
Southpoint GP, LLC: Delaware
John S. Clark II: United States of America
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP Number(s):
24906P109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 of the cover pages to this Schedule 13G.
Shares of Common Stock reported herein are held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of its or his pecuniary interest therein.
(b)
Percent of class:
The information required by this item with respect to each Reporting Person is set forth in Row 11 of the cover pages to this Schedule 13G. The ownership percentages are based on 199,749,333 outstanding shares of Common Stock as of February 20, 2026, as reported in the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by this item with respect to each Reporting Person is set forth in Row 5 of the cover pages to this Schedule 13G.
(ii) Shared power to vote or to direct the vote:
The information required by this item with respect to each Reporting Person is set forth in Row 6 of the cover pages to this Schedule 13G.
(iii) Sole power to dispose or to direct the disposition of:
The information required by this item with respect to each Reporting Person is set forth in Row 7 of the cover pages to this Schedule 13G.
(iv) Shared power to dispose or to direct the disposition of:
The information required by this item with respect to each Reporting Person is set forth in Row 8 of the cover pages to this Schedule 13G.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Southpoint Master Fund, LP
Signature:
/s/ John S. Clark II
Name/Title:
By Southpoint GP, LP, its General Partner, by Southpoint GP LLC, its General Partner, by John S. Clark II, Managing Member
Date:
03/18/2026
Southpoint Capital Advisors LP
Signature:
/s/ John S. Clark II
Name/Title:
By Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
Date:
03/18/2026
Southpoint Capital Advisors LLC
Signature:
/s/ John S. Clark II
Name/Title:
John S. Clark II, Managing Member
Date:
03/18/2026
Southpoint GP, LP
Signature:
/s/ John S. Clark II
Name/Title:
By Southpoint GP, LLC, its General Partner, byJohn S. Clark II, Managing Member
